AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 JUL 3 - (NewsRx.com & NewsRx.net) -- Phenoxodiol induces apoptosis in chemoresistant ovarian cancer cells. According to published research from the United States, "Interference with the innate apoptotic activity is a hallmark of neoplastic transformation and tumor formation.
"In this study we characterize the cytotoxic effect of phenoxodiol, a synthetic anticancer drug analog of genestein, and demonstrate the mechanism of action by which phenoxodiol affects the components of the Fas apoptotic pathway on ovarian cancer cells," wrote M. Kamsteeg and colleagues, Yale University School of Medicine.
"Primary ovarian cancer cells, isolated from ascitic fluids of ovarian cancer patients, resistant to conventional chemotherapy, undergo apoptosis following phenoxodiol treatment," the researchers stated.
"This effect is dependent upon the activation of the caspase system, inhibiting XIAP, an inhibitor of apoptosis, and disrupting FLICE inhibitory protein (FLIP) expression through the Akt signal transduction pathway. We suggest that phenoxodiol is an efficient inducer of cell death in ...
Source: HighBeam Research, Phenoxodiol induces apoptosis in chemoresistant ovarian cancer cells.